Intelligence · Clinical Development
Pipeline search results
Programs matching “vedolizumab” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 32 pipeline programs matching "vedolizumab" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Vedolizumab
Takeda
Ulcerative Colitis
9 trials -
Vedolizumab
Takeda
Colitis, Ulcerative
5 trials -
Vedolizumab
Takeda
Pouchitis
1 trial -
Vedolizumab
Takeda
Primary Sclerosing Cholangitis
1 trial -
Vedolizumab 300 mg IV
Takeda
Colitis, Ulcerative
1 trial -
Vedolizumab IV
Takeda
Crohn's Disease (CD)
1 trial -
Vedolizumab IV
Takeda
Ulcerative Colitis
4 trials -
Vedolizumab IV
Takeda
Moderately to Severely Active Ulcerative Colitis
1 trial -
Vedolizumab IV
Takeda
Crohn's Disease
2 trials -
Vedolizumab Placebo
Takeda
Hematopoietic Stem Cells
1 trial -
Vedolizumab SC
Takeda
Ulcerative Colitis
1 trial -
Vedolizumab SC
Takeda
Colitis, Ulcerative
1 trial -
Vedolizumab SC 108 mg
Takeda
Crohn's Disease
1 trial -
Vedolizumab-3041
Takeda
Active Chronic Pouchitis
1 trial -
VedolizumabSC-3003
Takeda
Active Ulcerative Colitis or Crohn’s Disease
1 trial -
VedolizumabSC-3004
Takeda
Ulcerative Colitis or Crohn’s Disease
1 trial -
Entyvio 300 mg powder for concentrate for solution for infusion
Takeda
Ulcerative Colitis or Crohn's Disease
1 trial -
Vedolizumab
Takeda
Collagenous Gastritis
1 trial -
Vedolizumab
Takeda
Celiac Disease
1 trial -
Vedolizumab
Takeda
Allogeneic Hematopoietic Stem Cell Transplantation
2 trials -
Vedolizumab 300 MG Injection [Entyvio]
Takeda
Immune Checkpoint Inhibitor-Related Colitis
1 trial -
Vedolizumab intravenous injection
Takeda
Ulcerative Colitis
1 trial -
Vedolizumab SC
Takeda
Healthy
1 trial -
Vedolizumab SC
Takeda
Healthy Volunteers
4 trials
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.